Body Composition Analyzers Market

研究執行與發布：MarketsandMarkets　·　發布日期 2026-08-27　·　341 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

完整報告名稱與涵蓋範圍

Body Composition Analyzers Market by Product (Bioimpedance Analyzer, DEXA Scan, Skinfold Caliper, Air Displacement Plethysmography, Hydrostatic Weighing), Usage (Professional, Consumer), Modality (Portable, Stationary), End User - Global Forecast to 2031

報告摘要

The global body composition analyzers market is anticipated to grow from USD 0.99 billion in 2026 to USD 1.39 billion by 2031, at a CAGR of 7.1% during the forecast period. Body composition analyzers are widely used by hospitals & clinics, fitness & wellness centers, academic & research centers, and home users. They are also used in monitoring and tailoring fitness programs based on individual body composition data. Emerging markets such as Asia Pacific offer lucrative market growth opportunities. Rising prevalence of obesity and metabolic disorders, growing adoption of preventive healthcare, and increasing demand for personalized nutrition and fitness programs drive the market. Furthermore, technological advancements in bioelectrical impedance analysis (BIA) and integration with digital health platforms and wearable devices enable more accurate, connected, and convenient body composition monitoring, driving the overall market. “Bioimpedance analyzers segment to exhibit the highest growth rate from 2026 to 2031” Based on product, the bioimpedance analyzers segment is likely to register the highest growth rate in the body composition analyzers market during the forecast period. Major driving factors include continuous improvements in bioimpedance technology to enhance accuracy, reliability, and user-friendliness. The rising demand for non-invasive body composition assessment, growing adoption of multifrequency and segmental analysis, and expansion of fitness and wellness programs also contribute to the segmental growth. Additionally, increasing home-based health monitoring and integration with connected devices and digital health platforms drive the segment. These trends are enhancing measurement accuracy, accessibility, personalization, and real-time health tracking across clinical and consumer applications. “Segmental body measurement segment captured the largest market share in 2025” Based on application, the segmental body measurement segment accounted for the largest share of the body composition analyzers market in 2025. Segmental body measurement offers more precise and accurate analysis compared with whole-body measurements, providing detailed insights into specific areas of the body. The segment is driven by growing demand for precise regional body composition assessment, particularly for monitoring fat distribution, muscle mass, and fluid balance. Increasing adoption in obesity management, sports performance, nutrition, and clinical care is expanding applications. Technological advances in multifrequency BIA, octopolar configurations, and digital analytics are improving regional measurement capabilities, while demand for personalized fitness and healthcare programs is encouraging broader adoption. “Asia Pacific to be the fastest-growing regional market between 2026 and 2031” Based on region, Asia Pacific is expected to register the highest growth rate in the body composition analyzers market during the forecast period, mainly due to rapid urbanization and lifestyle changes, such as sedentary habits and poor diets. These devices help address emerging health concerns by providing detailed insights into body composition, which reflects the growing need for effective health management solutions. The regional market is driven by rising obesity and metabolic disorders, increasing health and fitness awareness, expanding healthcare infrastructure, and growing disposable incomes. Adoption is further supported by the expansion of fitness clubs, wellness programs, and preventive healthcare initiatives. Demand for affordable, portable, and connected analyzers, particularly across India, China, Japan, and Southeast Asia, is also accelerating market penetration. Technological advancements in BIA and digital health integration are broadening clinical, fitness, and home-use applications. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25% • By Designation: Directors–25%, Managers–50%, and Others–25% • By Region: North America–43%, Europe–14%, Asia Pacific–26%, Latin America- 12%, and the Middle East & Africa- 5% Prominent players in the body composition analyzers market include GE HealthCare (US), OMRON Corporation (Japan), Hologic, Inc. (US), InBody Co., Ltd. (South Korea), Tanita Corporation (Japan), seca (Germany), Withings (France), SELVAS Healthcare, Inc. (South Korea), COSMED srl (Italy), and RJL Systems (US). Research Coverage This report studies the body composition analyzers market based on product, usage type, modality, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions). Reasons to Buy the Report The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence. This report provides insights into the following pointers: • Analysis of key drivers (Rising prevalence of obesity and focus on body fat and muscle mass assessment, Growing adoption of body composition analysis in weight management and preventive healthcare), restraints (Limited reimbursement for routine body composition assessment, High sensitivity of bioimpedance measurements to hydration status and measurement conditions), opportunities (Increasing establishment of fitness, wellness and sports performance centers, Mounting demand for connected and data-driven monitoring), and challenges (Lack of standardization, Competition from established clinical imaging technologies) influencing the growth of the body composition analyzers market • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the market • Market Development: Comprehensive information about lucrative markets – the report analyzes the market across varied regions • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players such as Omron Corporation (Japan), Hologic Inc. (US), and GE Healthcare (US)

授權報價

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

目錄 Table of Contents

1 INTRODUCTION 31 1.1 STUDY OBJECTIVES 31 1.2 MARKET DEFINITION 31 1.3 MARKET SCOPE 32 1.3.1 MARKET SEGMENTATION 32 1.3.2 INCLUSIONS & EXCLUSIONS 33 1.3.3 YEARS CONSIDERED 33 1.3.4 CURRENCY CONSIDERED 34 1.4 STAKEHOLDERS 34 1.5 SUMMARY OF CHANGES 34 2 EXECUTIVE SUMMARY 36 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 36 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 37 2.3 DISRUPTIVE TRENDS IN BODY COMPOSITION ANALYZERS MARKET 38 2.4 HIGH-GROWTH SEGMENTS 39 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 40 3 PREMIUM INSIGHTS 41 3.1 BODY COMPOSITION ANALYZERS MARKET OVERVIEW 41 3.2 EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY END USER AND COUNTRY (2025) 42 3.3 BODY COMPOSITION ANALYZERS MARKET: REGION (2026−2031) 43 4 MARKET OVERVIEW 44 4.1 INTRODUCTION 44 4.2 MARKET DYNAMICS 44 4.2.1 DRIVERS 45 4.2.1.1 Rising prevalence of obesity and increasing focus on body fat and muscle mass assessment 45 4.2.1.2 Growing adoption of body composition analysis in weight management and preventive healthcare 46 4.2.1.3 Growing geriatric population and rising demand for sarcopenia & muscle mass monitoring 47 4.2.2 RESTRAINTS 48 4.2.2.1 Limited reimbursement for routine body composition assessment 48 4.2.2.2 High sensitivity of bioimpedance measurements to hydration status and measurement conditions 49 4.2.3 OPPORTUNITIES 50 4.2.3.1 Increasing establishment of fitness, wellness, and sports performance centers 50 4.2.3.2 Growing demand for connected and data-driven monitoring 51 4.2.4 CHALLENGES 52 4.2.4.1 Lack of standardization across BIA devices, algorithms, and measurement protocols 52 4.2.4.2 Competition from established clinical imaging technologies such as CT and MRI 53 4.3 UNMET NEEDS AND WHITE SPACES 54 4.3.1 UNMET NEEDS IN BODY COMPOSITION ANALYZERS MARKET 54 4.3.2 WHITE SPACE OPPORTUNITIES 55 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 55 4.4.1 INTERCONNECTED MARKETS 55 4.4.2 CROSS-SECTOR OPPORTUNITIES 56 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 56 4.5.1 STRATEGIC MOVES IN BODY COMPOSITION ANALYZERS MARKET 57 5 INDUSTRY TRENDS 58 5.1 PORTER’S FIVE FORCES ANALYSIS 58 5.1.1 THREAT FROM NEW ENTRANTS 59 5.1.2 THREAT FROM SUBSTITUTES 60 5.1.3 BARGAINING POWER OF SUPPLIERS 60 5.1.4 BARGAINING POWER OF BUYERS 60 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 60 5.2 MACROECONOMIC INDICATORS 61 5.2.1 INTRODUCTION 61 5.2.2 GDP TRENDS AND FORECAST 61 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 62 5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY 62 5.3 SUPPLY CHAIN ANALYSIS 62 5.4 VALUE CHAIN ANALYSIS 64 5.5 ECOSYSTEM ANALYSIS 65 5.5.1 MANUFACTURERS 66 5.5.2 END USERS 67 5.5.3 REGULATORY BODIES 68 5.6 PRICING ANALYSIS 68 5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023–2025 68 5.6.2 AVERAGE SELLING PRICE TREND, BY MODALITY, 2023–2025 71 5.6.3 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 71 5.7 TRADE ANALYSIS 74 5.7.1 IMPORT DATA (HS CODE 901819) 74 5.7.2 EXPORT DATA (HS CODE 901819) 75 5.7.3 IMPORT DATA (HS CODE 903180) 76 5.7.4 EXPORT DATA FOR (HS CODE 903180) 76 5.8 REIMBURSEMENT SCENARIO 77 5.9 KEY CONFERENCES & EVENTS, 2026–2027 78 5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 79 5.11 INVESTMENT & FUNDING SCENARIO 80 5.12 CASE STUDY ANALYSIS 81 5.13 IMPACT OF 2025 US TARIFFS—BODY COMPOSITION ANALYZERS MARKET 82 5.13.1 INTRODUCTION 82 5.13.2 KEY TARIFF RATES 83 5.13.3 PRICE IMPACT ANALYSIS 84 5.13.4 IMPACT ON COUNTRIES/REGIONS 85 5.13.5 IMPACT ON END-USE SEGMENTS 86 5.13.5.1 Hospitals & clinics 86 5.13.5.2 Fitness clubs & wellness centers 86 5.13.5.3 Academic & research centers 87 5.13.5.4 Home Users 87 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 88 6.1 TECHNOLOGY ANALYSIS 88 6.1.1 KEY EMERGING TECHNOLOGIES 88 6.1.1.1 Wearable body composition monitoring 88 6.1.1.2 AI-enabled body composition analysis and smartphone-based assessment 88 6.1.2 COMPLEMENTARY TECHNOLOGIES 89 6.1.2.1 Cloud-based body composition data platforms 89 6.1.2.2 Digital nutrition and weight-management technologies 89 6.1.3 ADJACENT TECHNOLOGIES 89 6.1.3.1 MRI and CT-based body composition analysis 89 6.1.3.2 Ultrasound body composition assessment 89 6.2 TECHNOLOGY/PRODUCT ROADMAP 90 6.2.1 NEAR-TERM (2025–2027) 90 6.2.2 MID-TERM (2028–2030) 90 6.2.3 LONG-TERM (2030+) 91 6.3 PATENT ANALYSIS 91 6.3.1 JURISDICTION AND TOP APPLICANT ANALYSIS 91 6.4 FUTURE APPLICATIONS 94 6.4.1 AI-ASSISTED PERSONALIZED BODY COMPOSITION MANAGEMENT 95 6.4.2 REMOTE AND HOME-BASED BODY COMPOSITION MONITORING 95 6.4.3 OBESITY AND WEIGHT-MANAGEMENT APPLICATIONS 95 6.4.4 SARCOPENIA AND MUSCLE-HEALTH ASSESSMENT 95 6.5 IMPACT OF AI/GEN AI ON BODY COMPOSITION ANALYZERS 95 6.5.1 INTRODUCTION 95 6.5.2 MARKET POTENTIAL OF AI IN BODY COMPOSITION ANALYZERS 96 6.5.3 AI USE CASES 96 6.5.4 KEY COMPANIES IMPLEMENTING AI 98 7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 99 7.1 REGULATORY LANDSCAPE 99 7.1.1 REGULATORY FRAMEWORK 99 7.1.1.1 North America 99 7.1.1.2 Europe 99 7.1.1.3 Asia Pacific 99 7.1.1.4 Latin America 100 7.1.1.5 Middle East & Africa 100 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100 7.1.3 INDUSTRY STANDARDS 102 7.2 SUSTAINABILITY INITIATIVES 103 7.2.1 REDUCING MEDICAL WASTE & USE OF LOWER-IMPACT MATERIALS AND PACKAGING 103 7.2.2 WATER, ENERGY, AND RESOURCE EFFICIENCY 103 7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 103 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 105 8.1 DECISION-MAKING PROCESS 105 8.2 KEY STAKEHOLDERS & BUYING CRITERIA 105 8.2.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 106 8.2.2 BUYING CRITERIA 107 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 108 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 109 8.5 MARKET PROFITABILITY 109 9 BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT 111 9.1 INTRODUCTION 112 9.2 BIOIMPEDANCE ANALYZERS 114 9.2.1 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS 116 9.2.1.1 Detailed body water and segmental assessment supporting demand 116 9.2.1.2 Global volume analysis of multi-frequency bioimpedance analyzers, 2024–2031 (units) 118 9.2.2 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS 118 9.2.2.1 Cost-effective assessment expanding accessibility 118 9.2.2.2 Global volume analysis of single-frequency bioimpedance analyzers, 2024–2031 (units) 121 9.2.3 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS 121 9.2.3.1 Enhanced fluid assessment and practical measurement supporting adoption 121 9.2.3.2 Global volume analysis of dual-frequency bioimpedance analyzers, 2024–2031 (units) 123 9.3 DUAL-ENERGY X-RAY ABSORPTIOMETRY EQUIPMENT 123 9.3.1 COMPREHENSIVE BONE AND BODY COMPOSITION ASSESSMENT SUPPORTING ADOPTION 123 9.4 SKINFOLD CALIPERS 125 9.4.1 SIMPLE MEASUREMENT OF SUBCUTANEOUS FAT SUPPORTING CONTINUED USE 125 9.5 AIR DISPLACEMENT PLETHYSMOGRAPHY EQUIPMENT 127 9.5.1 RAPID ASSESSMENT AND COST-EFFECTIVE TESTING SUPPORTING ADOPTION 127 9.6 HYDROSTATIC WEIGHING EQUIPMENT 128 9.6.1 ESTABLISHED BODY DENSITY METHOD SUPPORTING NICHE APPLICATIONS 128 10 BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE 130 10.1 INTRODUCTION 131 10.2 PROFESSIONAL-GRADE BODY COMPOSITION ANALYZERS 132 10.2.1 EXPANDING FITNESS AND SPECIALIZED ASSESSMENT FACILITIES SUPPORTING DEMAND 132 10.3 CONSUMER-GRADE BODY COMPOSITION ANALYZERS 133 10.3.1 ADVANCEMENTS IN CONNECTED AND HOME-BASED MONITORING SUPPORTING GROWTH 133 11 BODY COMPOSITION ANALYZERS MARKET, BY MODALITY 135 11.1 INTRODUCTION 136 11.2 PORTABLE BODY COMPOSITION ANALYZERS 137 11.2.1 MOBILITY AND WIRELESS DATA CONNECTIVITY SUPPORTING BROADER ADOPTION 137 11.3 STATIONARY/BENCHTOP BODY COMPOSITION ANALYZERS 138 11.3.1 STANDARDIZED MEASUREMENT AND PROFESSIONAL-GRADE FEATURES SUPPORTING ADOPTION 138 12 BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION 140 12.1 INTRODUCTION 141 12.2 SEGMENTAL BODY MEASUREMENT 142 12.2.1 DETAILED REGIONAL ANALYSIS SUPPORTING PERSONALIZED ASSESSMENT 142 12.3 WHOLE-BODY MEASUREMENT 144 12.3.1 COMPREHENSIVE BODY COMPOSITION ASSESSMENT SUPPORTING WIDER APPLICATION 144 13 BODY COMPOSITION ANALYZERS MARKET, BY END USER 146 13.1 INTRODUCTION 147 13.2 FITNESS CLUBS & WELLNESS CENTERS 148 13.2.1 EXPANDING FITNESS INFRASTRUCTURE SUPPORTING DEMAND 148 13.3 HOSPITALS & CLINICS 150 13.3.1 OSTEOPOROSIS ASSESSMENT AND CLINICAL BODY COMPOSITION MONITORING SUPPORTING DEMAND 150 13.4 ACADEMIC & RESEARCH CENTERS 151 13.4.1 INCREASING RESEARCH FUNDING AND TECHNOLOGY VALIDATION ACTIVITIES SUPPORTING DEMAND 151 13.5 HOME USERS 152 13.5.1 CONNECTED AND USER-FRIENDLY DEVICES SUPPORTING HOME-BASED MONITORING 152 14 BODY COMPOSITION ANALYZERS MARKET, BY REGION 154 14.1 INTRODUCTION 155 14.2 NORTH AMERICA 155 14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 156 14.2.2 NORTH AMERICA: VOLUME ANALYSIS, 2024–2031 (UNITS) 157 14.2.3 US 160 14.2.3.1 High Obesity Prevalence and Growing Need for Direct Body Composition Assessment Driving Market Growth 160 14.2.4 CANADA 163 14.2.4.1 Increasing Adiposity and Growing Attention to Abdominal Fat Assessment Supporting Market Growth 163 14.3 EUROPE 166 14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 166 14.3.2 EUROPE: VOLUME ANALYSIS, 2024–2031 (UNITS) 167 14.3.3 GERMANY 170 14.3.3.1 Widespread Excess Weight and Rising Demand for More Detailed Body Assessment Supporting Market Growth 170 14.3.4 FRANCE 173 14.3.4.1 Growing Clinical Use of Body Composition Assessment in Obesity Care Supporting Market Growth 173 14.3.5 UK 176 14.3.5.1 Expansion of Large-Scale Body Composition Research Supporting Demand for Advanced Assessment Technologies 176 14.3.6 ITALY 178 14.3.6.1 Growing Adoption of Body Composition Assessment in Obesity Management Supporting Market Expansion 178 14.3.7 SPAIN 181 14.3.7.1 Increasing Use of Body Composition Monitoring in Obesity and Metabolic Health Supporting Market Growth 181 14.3.8 REST OF EUROPE 184 14.4 ASIA PACIFIC 186 14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 186 14.4.2 ASIA PACIFIC: VOLUME ANALYSIS, 2024–2031 (UNITS) 188 14.4.3 CHINA 191 14.4.3.1 Rising cases of obesity in children to propel the market 191 14.4.4 JAPAN 194 14.4.4.1 Growing Emphasis on Healthy Aging and Muscle Mass Assessment Creating Demand for Body Composition Technologies 194 14.4.5 INDIA 197 14.4.5.1 Expanding Obesity Management Initiatives and Greater Focus on Body Fat Assessment Driving Market Growth 197 14.4.6 AUSTRALIA 200 14.4.6.1 Use of body composition assessment in high-performance sports to sustain demand 200 14.4.7 SOUTH KOREA 203 14.4.7.1 Evolving Obesity Assessment Practices Driving Demand for Body Composition Technologies 203 14.4.8 REST OF ASIA PACIFIC 206 14.5 LATIN AMERICA 208 14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 208 14.5.2 LATIN AMERICA: VOLUME ANALYSIS, 2024–2031 (UNITS) 209 14.5.3 BRAZIL 212 14.5.3.1 Strengthening Obesity Management Practices Creating Opportunities for Body Composition Assessment 212 14.5.4 MEXICO 215 14.5.4.1 Increasing Emphasis on Comprehensive Obesity Assessment Creating Opportunities for Body Composition Technologies 215 14.5.5 REST OF LATIN AMERICA 218 14.6 MIDDLE EAST & AFRICA 220 14.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 220 14.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, 2024–2031 (UNITS) 221 14.6.3 GCC COUNTRIES 224 14.6.3.1 Kingdom of Saudi Arabia 227 14.6.3.1.1 Expanding weight management programs creating opportunities for body composition assessment 227 14.6.3.2 UAE 229 14.6.3.2.1 Rising emphasis on obesity prevention and weight management to propel market 229 14.6.4 REST OF GCC COUNTRIES 232 14.6.5 REST OF MIDDLE EAST & AFRICA 234 15 COMPETITIVE LANDSCAPE 237 15.1 OVERVIEW 237 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 237 15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE BODY COMPOSITION ANALYZERS MARKET 238 15.3 REVENUE ANALYSIS 239 15.4 MARKET SHARE ANALYSIS 240 15.4.1 GLOBAL BODY COMPOSITION ANALYZERS MARKET SHARE ANALYSIS, 2025 240 15.4.2 US BODY COMPOSITION ANALYZERS MARKET SHARE ANALYSIS, 2025 241 15.4.3 EUROPE BODY COMPOSITION ANALYZERS MARKET SHARE ANALYSIS, 2025 243 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 245 15.5.1 STARS 245 15.5.2 EMERGING LEADERS 245 15.5.3 PERVASIVE PLAYERS 245 15.5.4 PARTICIPANTS 245 15.6 COMPANY FOOTPRINT 247 15.6.1 COMPANY FOOTPRINT: KEY PLAYERS, 2025 247 15.6.1.1 Company footprint 247 15.6.1.2 Region footprint 248 15.6.1.3 Product footprint 249 15.6.1.4 Modality footprint 250 15.6.1.5 Usage type footprint 251 15.6.1.6 Application footprint 252 15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 253 15.7.1 PROGRESSIVE COMPANIES 253 15.7.2 RESPONSIVE COMPANIES 253 15.7.3 DYNAMIC COMPANIES 253 15.7.4 STARTING BLOCKS 253 15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 255 15.7.5.1 Detailed list of key startups/SMEs 255 15.7.5.2 Competitive benchmarking of key startups/SMEs 256 15.8 COMPANY VALUATION & FINANCIAL METRICS 257 15.8.1 FINANCIAL METRICS 257 15.8.2 COMPANY VALUATION 257 15.9 BRAND/PRODUCT COMPARISON 258 15.10 COMPETITIVE SCENARIO 259 15.10.1 PRODUCT LAUNCHES & APPROVALS 259 15.10.2 DEALS 260 15.10.3 EXPANSIONS 261 15.10.4 OTHER DEVELOPMENTS 261 16 COMPANY PROFILES 262 16.1 KEY PLAYERS 262 16.1.1 GE HEALTHCARE 262 16.1.1.1 Business overview 262 16.1.1.2 Products offered 263 16.1.1.3 Recent developments 264 16.1.1.3.1 Deals 264 16.1.1.4 MnM view 264 16.1.1.4.1 Key strengths/Right to win 264 16.1.1.4.2 Strategic choices 265 16.1.1.4.3 Weaknesses & competitive threats 265 16.1.2 OMRON CORPORATION 266 16.1.2.1 Business overview 266 16.1.2.2 Products offered 267 16.1.2.3 Recent developments 268 16.1.2.3.1 Deals 268 16.1.2.3.2 Expansions 269 16.1.2.4 MnM view 269 16.1.2.4.1 Key strengths/Right to win 269 16.1.2.4.2 Strategic choices 269 16.1.2.4.3 Weaknesses & competitive threats 269 16.1.3 HOLOGIC, INC. 270 16.1.3.1 Business overview 270 16.1.3.2 Products offered 271 16.1.3.3 Recent developments 272 16.1.3.3.1 Deals 272 16.1.3.4 MnM view 272 16.1.3.4.1 Key strengths/Right to win 272 16.1.3.4.2 Strategic choices 272 16.1.3.4.3 Weaknesses & competitive threats 272 16.1.4 INBODY CO., LTD. 273 16.1.4.1 Business overview 273 16.1.4.2 Products offered 274 16.1.4.3 Recent developments 275 16.1.4.3.1 Product launches & approvals 275 16.1.4.3.2 Expansions 276 16.1.4.4 MnM view 276 16.1.4.4.1 Key strengths/Right to win 276 16.1.4.4.2 Strategic choices 276 16.1.4.4.3 Weaknesses & competitive threats 276 16.1.5 SELVAS HEALTHCARE, INC. 277 16.1.5.1 Business overview 277 16.1.5.2 Products offered 278 16.1.5.3 Recent developments 279 16.1.5.3.1 Other developments 279 16.1.6 IMPEDIMED LIMITED 280 16.1.6.1 Business overview 280 16.1.6.2 Products offered 281 16.1.7 DMS IMAGING 282 16.1.7.1 Business overview 282 16.1.7.2 Products offered 283 16.1.7.3 Recent developments 284 16.1.7.3.1 Product launches & approvals 284 16.1.7.3.2 Deals 284 16.1.8 A&D COMPANY, LIMITED 285 16.1.8.1 Business overview 285 16.1.8.2 Products offered 286 16.1.8.3 Recent developments 287 16.1.8.3.1 Deals 287 16.1.9 XIAOMI CORPORATION 288 16.1.9.1 Business overview 288 16.1.9.2 Products offered 289 16.1.9.3 Recent developments 290 16.1.9.3.1 Product launches & approvals 290 16.1.10 TANITA CORPORATION 291 16.1.10.1 Business overview 291 16.1.10.2 Products offered 291 16.1.10.3 Recent developments 293 16.1.10.3.1 Product launches & approvals 293 16.1.10.3.2 Deals 293 16.1.11 SECA 294 16.1.11.1 Business overview 294 16.1.11.2 Products offered 294 16.1.11.3 Recent developments 295 16.1.11.3.1 Product launches 295 16.1.11.3.2 Deals 295 16.1.12 WITHINGS 296 16.1.12.1 Business overview 296 16.1.12.2 Products offered 296 16.1.12.3 Recent developments 297 16.1.12.3.1 Product & services launches 297 16.1.12.3.2 Deals 297 16.1.13 COSMED S.R.L. 299 16.1.13.1 Business overview 299 16.1.13.2 Products offered 299 16.1.13.3 Recent developments 300 16.1.13.3.1 Deals 300 16.1.14 RJL SYSTEMS 301 16.1.14.1 Business overview 301 16.1.14.2 Products offered 301 16.1.15 CHARDER ELECTRONIC CO., LTD. 302 16.1.15.1 Business overview 302 16.1.15.2 Products offered 302 16.1.15.3 Recent developments 303 16.1.15.3.1 Other developments 303 16.1.16 BODYSTAT LIMITED 304 16.1.16.1 Business overview 304 16.1.16.2 Products offered 304 16.2 OTHER PLAYERS 305 16.2.1 MALTRON INTERNATIONAL LTD. 305 16.2.2 AKERN S.R.L. 306 16.2.3 BIOTEKNA 307 16.2.4 BIODYNAMICS CORPORATION 307 16.2.5 MICROLIFE CORPORATION 308 16.2.6 NUMED S.A.R.L. 309 16.2.7 TONGYONG TIZHI HEALTH TECHNOLOGY CO., LTD. 310 16.2.8 FOOK TIN TECHNOLOGIES LTD. 311 16.2.9 OSTEOSYS CORP. 312 16.2.10 EXERTECH 312 16.2.11 SHANGHAI GOLDENWELL MEDICAL TECHNOLOGY CO., LTD. 313 17 RESEARCH METHODOLOGY 314 17.1 RESEARCH DATA 314 17.1.1 SECONDARY DATA 315 17.1.1.1 Key secondary sources 316 17.1.2 PRIMARY DATA 316 17.1.2.1 Primary sources 317 17.1.2.2 Key data from primary sources 318 17.1.2.3 Key industry insights 318 17.1.2.4 Breakdown of primaries 319 17.2 MARKET SIZE ESTIMATION 320 17.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH 322 17.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 323 17.2.3 APPROACH 3: TOP-DOWN APPROACH 323 17.2.4 APPROACH 4: BOTTOM-UP APPROACH 324 17.2.5 APPROACH 5: PRIMARY INTERVIEWS 324 17.2.6 APPROACH 6: DEMAND-SIDE APPROACH 325 17.2.7 APPROACH 7: VOLUME DATA ANALYSIS 326 17.3 DATA TRIANGULATION AND MARKET BREAKDOWN 329 17.4 MARKET SHARE ASSESSMENT 330 17.5 RESEARCH ASSUMPTIONS 330 17.5.1 STUDY ASSUMPTIONS 330 17.5.2 GROWTH RATE ASSUMPTIONS 330 17.6 RISK ASSESSMENT 331 17.6.1 RESEARCH LIMITATIONS 331 18 APPENDIX 332 18.1 DISCUSSION GUIDE 332 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 337 18.3 CUSTOMIZATION OPTIONS 339 18.3.1 PRODUCT ANALYSIS 339 18.3.2 COMPANY INFORMATION 339 18.3.3 GEOGRAPHIC ANALYSIS 339 18.4 RELATED REPORTS 339 18.5 AUTHOR DETAILS 340

圖表清單 List of Tables & Figures

TABLE 1 STANDARD CURRENCY CONVERSION RATES 34 TABLE 2 BODY COMPOSITION ANALYZERS MARKET: PORTER’S FIVE FORCES ANALYSIS 58 TABLE 3 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION) 61 TABLE 4 LIST OF KEY BODY COMPOSITION ANALYZERS MANUFACTURERS 67 TABLE 5 LIST OF KEY END USERS 67 TABLE 6 LIST OF KEY REGULATORY BODIES 68 TABLE 7 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2023–2025 (USD) 68 TABLE 8 AVERAGE SELLING PRICE TREND, BY MODALITY, 2023–2025 (USD) 71 TABLE 9 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 (USD) 71 TABLE 10 IMPORT DATA FOR HS CODE 901819-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 74 TABLE 11 EXPORT DATA FOR HS CODE 901819-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 75 TABLE 12 IMPORT DATA FOR HS CODE 903180-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 76 TABLE 13 EXPORT DATA FOR HS CODE 903180-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 76 TABLE 14 BODY COMPOSITION ANALYZERS MARKET: MAJOR CONFERENCES & EVENTS, 2026–2027 78 TABLE 15 SECA MBCA – BODY COMPOSITION MONITORING DURING INJURY REHABILITATION 81 TABLE 16 EVOLT 360 – GNC TULSA HILLS NUTRITION RETAIL APPLICATION 81 TABLE 17 CHARDER ELECTRONIC – TAIWAN TECH FITNESS ASSESSMENT PROGRAM 82 TABLE 18 RECIPROCAL TARIFF RATES ADJUSTED BY US, 2025 83 TABLE 19 KEY PRODUCT-RELATED TARIFFS 84 TABLE 20 NORTH AMERICA: IMPACT OF US TARIFF ON CANADA 85 TABLE 21 ASIA PACIFIC: IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA 85 TABLE 22 EUROPE: IMPACT OF US TARIFF ON GERMANY AND UK 85 TABLE 23 LATIN AMERICA: IMPACT OF US TARIFF ON MEXICO 86 TABLE 24 BODY COMPOSITION ANALYZERS MARKET: KEY PATENTS, 2015–2026 93 TABLE 25 COMPANIES IMPLEMENTING AI 98 TABLE 26 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100 TABLE 27 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101 TABLE 28 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101 TABLE 29 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102 TABLE 30 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102 TABLE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BODY COMPOSITION ANALYZERS 107 TABLE 32 KEY BUYING CRITERIA FOR BODY COMPOSITION ANALYZERS, BY END USER 108 TABLE 33 BODY COMPOSITION ANALYZERS MARKET: ADOPTION BARRIERS & INTERNAL CHALLENGES 108 TABLE 34 BODY COMPOSITION ANALYZERS MARKET: UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 109 TABLE 35 BODY COMPOSITION ANALYZERS MARKET: KEY PROFITABILITY DRIVERS 110 TABLE 36 BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 112 TABLE 37 PRODUCT: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 113 TABLE 38 BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 114 TABLE 39 BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 115 TABLE 40 KEY PLAYERS PROVIDING MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS 116 TABLE 41 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117 TABLE 42 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2024–2031 (UNITS) 118 TABLE 43 KEY PLAYERS PROVIDING SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS 119 TABLE 44 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 120 TABLE 45 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2024–2031 (UNITS) 121 TABLE 46 KEY PLAYERS PROVIDING DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS 122 TABLE 47 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 122 TABLE 48 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2024–2031 (UNITS) 123 TABLE 49 KEY PLAYERS PROVIDING DUAL-ENERGY X-RAY ABSORPTIOMETRY 124 TABLE 50 DUAL-ENERGY X-RAY ABSORPTIOMETRY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124 TABLE 51 KEY PLAYERS PROVIDING SKINFOLD CALIPERS 125 TABLE 52 SKINFOLD CALIPERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126 TABLE 53 KEY PLAYERS PROVIDING AIR DISPLACEMENT PLETHYSMOGRAPHY 127 TABLE 54 AIR DISPLACEMENT PLETHYSMOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 55 KEY PLAYERS PROVIDING HYDROSTATIC WEIGHING EQUIPMENT 128 TABLE 56 HYDROSTATIC WEIGHING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 57 BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 131 TABLE 58 USAGE TYPE: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 59 PROFESSIONAL-GRADE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 60 CONSUMER-GRADE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 61 BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 136 TABLE 62 MODALITY: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 63 PORTABLE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 137 TABLE 64 STATIONARY/BENCHTOP BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 65 BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 141 TABLE 66 APPLICATION: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 67 BODY COMPOSITION ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 68 BODY COMPOSITION ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 69 BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 147 TABLE 70 END USER: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 71 BODY COMPOSITION ANALYZERS MARKET FOR FITNESS CLUBS & WELLNESS CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 72 BODY COMPOSITION ANALYZERS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 73 BODY COMPOSITION ANALYZERS MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 74 BODY COMPOSITION ANALYZERS MARKET FOR HOME USERS, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 75 BODY COMPOSITION ANALYZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 155 TABLE 76 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2024–2031 (UNITS) 157 TABLE 77 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 78 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 158 TABLE 79 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 158 TABLE 80 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 159 TABLE 81 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 159 TABLE 82 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 159 TABLE 83 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 160 TABLE 84 US: MACROECONOMIC INDICATORS 161 TABLE 85 US: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 161 TABLE 86 US: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 161 TABLE 87 US: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 162 TABLE 88 US: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 162 TABLE 89 US: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 162 TABLE 90 US: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 163 TABLE 91 CANADA: MACROECONOMIC INDICATORS 163 TABLE 92 CANADA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 164 TABLE 93 CANADA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 164 TABLE 94 CANADA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 164 TABLE 95 CANADA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 165 TABLE 96 CANADA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 165 TABLE 97 CANADA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 165 TABLE 98 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2024–2031 (UNITS) 167 TABLE 99 EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 100 EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 168 TABLE 101 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 168 TABLE 102 EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 168 TABLE 103 EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 169 TABLE 104 EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 169 TABLE 105 EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 169 TABLE 106 GERMANY: MACROECONOMIC INDICATORS 170 TABLE 107 GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 171 TABLE 108 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 171 TABLE 109 GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 171 TABLE 110 GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 172 TABLE 111 GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 172 TABLE 112 GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 172 TABLE 113 FRANCE: MACROECONOMIC INDICATORS 173 TABLE 114 FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 174 TABLE 115 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 174 TABLE 116 FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 174 TABLE 117 FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 175 TABLE 118 FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 175 TABLE 119 FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 175 TABLE 120 UK: MACROECONOMIC INDICATORS 176 TABLE 121 UK: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 176 TABLE 122 UK: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 177 TABLE 123 UK: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 177 TABLE 124 UK: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 177 TABLE 125 UK: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 178 TABLE 126 UK: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 178 TABLE 127 ITALY: MACROECONOMIC INDICATORS 179 TABLE 128 ITALY: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 179 TABLE 129 ITALY: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 179 TABLE 130 ITALY: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 180 TABLE 131 ITALY: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 180 TABLE 132 ITALY: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 180 TABLE 133 ITALY: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 181 TABLE 134 SPAIN: MACROECONOMIC INDICATORS 181 TABLE 135 SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 182 TABLE 136 SPAIN: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 182 TABLE 137 SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 182 TABLE 138 SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 183 TABLE 139 SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 183 TABLE 140 SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 183 TABLE 141 REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 184 TABLE 142 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 184 TABLE 143 REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 185 TABLE 144 REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 185 TABLE 145 REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 185 TABLE 146 REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 186 TABLE 147 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2024–2031 (UNITS) 188 TABLE 148 ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 149 ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 189 TABLE 150 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 189 TABLE 151 ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 189 TABLE 152 ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 190 TABLE 153 ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 190 TABLE 154 ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 190 TABLE 155 CHINA: MACROECONOMIC INDICATORS 191 TABLE 156 CHINA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 192 TABLE 157 CHINA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 192 TABLE 158 CHINA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 192 TABLE 159 CHINA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 193 TABLE 160 CHINA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 193 TABLE 161 CHINA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 193 TABLE 162 JAPAN: MACROECONOMIC INDICATORS 194 TABLE 163 JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 195 TABLE 164 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 195 TABLE 165 JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 195 TABLE 166 JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 196 TABLE 167 JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 196 TABLE 168 JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 196 TABLE 169 INDIA: MACROECONOMIC INDICATORS 197 TABLE 170 INDIA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 198 TABLE 171 INDIA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 198 TABLE 172 INDIA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 198 TABLE 173 INDIA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 199 TABLE 174 INDIA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 199 TABLE 175 INDIA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 199 TABLE 176 AUSTRALIA: MACROECONOMIC INDICATORS 200 TABLE 177 AUSTRALIA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 201 TABLE 178 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 201 TABLE 179 AUSTRALIA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 201 TABLE 180 AUSTRALIA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 202 TABLE 181 AUSTRALIA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 202 TABLE 182 AUSTRALIA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 202 TABLE 183 SOUTH KOREA: MACROECONOMIC INDICATORS 203 TABLE 184 SOUTH KOREA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 204 TABLE 185 SOUTH KOREA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 204 TABLE 186 SOUTH KOREA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 204 TABLE 187 SOUTH KOREA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 205 TABLE 188 SOUTH KOREA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 205 TABLE 189 SOUTH KOREA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 205 TABLE 190 REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 206 TABLE 191 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 206 TABLE 192 REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 207 TABLE 193 REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 207 TABLE 194 REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 207 TABLE 195 REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 208 TABLE 196 LATIN AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2024–2031 (UNITS) 209 TABLE 197 LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 198 LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 210 TABLE 199 LATIN AMERICA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 210 TABLE 200 LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 210 TABLE 201 LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 211 TABLE 202 LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 211 TABLE 203 LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 211 TABLE 204 BRAZIL: MACROECONOMIC INDICATORS 212 TABLE 205 BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 213 TABLE 206 BRAZIL: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 213 TABLE 207 BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 213 TABLE 208 BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 214 TABLE 209 BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 214 TABLE 210 BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 214 TABLE 211 MEXICO: MACROECONOMIC INDICATORS 215 TABLE 212 MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 216 TABLE 213 MEXICO: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 216 TABLE 214 MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 216 TABLE 215 MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 217 TABLE 216 MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 217 TABLE 217 MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 217 TABLE 218 REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 218 TABLE 219 REST OF LATIN AMERICA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 218 TABLE 220 REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 219 TABLE 221 REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 219 TABLE 222 REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 219 TABLE 223 REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 220 TABLE 224 MIDDLE EAST & AFRICA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2024–2031 (UNITS) 221 TABLE 225 MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 221 TABLE 226 MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 222 TABLE 227 MIDDLE EAST & AFRICA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 222 TABLE 228 MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 222 TABLE 229 MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 223 TABLE 230 MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 223 TABLE 231 MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 223 TABLE 232 GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 233 GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 225 TABLE 234 GCC COUNTRIES: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 225 TABLE 235 GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 225 TABLE 236 GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 226 TABLE 237 GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 226 TABLE 238 GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 226 TABLE 239 KINGDOM OF SAUDI ARABIA: MACROECONOMIC INDICATORS 227 TABLE 240 KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 227 TABLE 241 KINGDOM OF SAUDI ARABIA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 228 TABLE 242 KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 228 TABLE 243 KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 228 TABLE 244 KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 229 TABLE 245 KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 229 TABLE 246 UAE: MACROECONOMIC INDICATORS 230 TABLE 247 UAE: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 230 TABLE 248 UAE: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 230 TABLE 249 UAE: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 231 TABLE 250 UAE: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 231 TABLE 251 UAE: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 231 TABLE 252 UAE: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 232 TABLE 253 REST OF GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 232 TABLE 254 REST OF GCC COUNTRIES: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 233 TABLE 255 REST OF GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 233 TABLE 256 REST OF GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 233 TABLE 257 REST OF GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 234 TABLE 258 REST OF GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 234 TABLE 259 REST OF MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 235 TABLE 260 REST OF MIDDLE EAST & AFRICA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 235 TABLE 261 REST OF MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 235 TABLE 262 REST OF MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 236 TABLE 263 REST OF MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 236 TABLE 264 REST OF MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 236 TABLE 265 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, JANUARY 2023–JULY 2026 238 TABLE 266 BODY COMPOSITION ANALYZERS MARKET: DEGREE OF COMPETITION 241 TABLE 267 US BODY COMPOSITION ANALYZERS MARKET: DEGREE OF COMPETITION 242 TABLE 268 EUROPE BODY COMPOSITION ANALYZERS MARKET: DEGREE OF COMPETITION 244 TABLE 269 BODY COMPOSITION ANALYZERS MARKET: REGION FOOTPRINT 248 TABLE 270 BODY COMPOSITION ANALYZERS MARKET: PRODUCT FOOTPRINT 249 TABLE 271 BODY COMPOSITION ANALYZERS MARKET: MODALITY FOOTPRINT 250 TABLE 272 BODY COMPOSITION ANALYZERS MARKET: USAGE TYPE FOOTPRINT 251 TABLE 273 BODY COMPOSITION ANALYZERS MARKET: APPLICATION FOOTPRINT 252 TABLE 274 BODY COMPOSITION ANALYZERS MARKET: DETAILED LIST OF KEY START-UPS/SMES 255 TABLE 275 BODY COMPOSITION ANALYZERS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 256 TABLE 276 BODY COMPOSITION ANALYZERS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 259 TABLE 277 BODY COMPOSITION ANALYZERS MARKET: DEALS, JANUARY 2023– JULY 2026 260 TABLE 278 BODY COMPOSITION ANALYZERS MARKET: EXPANSIONS, JANUARY 2023–JULY 2026 261 TABLE 279 BODY COMPOSITION ANALYZERS MARKET: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 261 TABLE 280 GE HEALTHCARE: COMPANY OVERVIEW 262 TABLE 281 GE HEALTHCARE: PRODUCTS OFFERED 263 TABLE 282 GE HEALTHCARE: DEALS, JANUARY 2023–JULY 2026 264 TABLE 283 OMRON CORPORATION: COMPANY OVERVIEW 266 TABLE 284 OMRON CORPORATION: PRODUCTS OFFERED 267 TABLE 285 OMRON CORPORATION: DEALS, JANUARY 2023–JULY 2026 268 TABLE 286 OMRON CORPORATION: EXPANSIONS, JANUARY 2023–JULY 2026 269 TABLE 287 HOLOGIC, INC.: COMPANY OVERVIEW 270 TABLE 288 HOLOGIC, INC.: PRODUCTS OFFERED 271 TABLE 289 HOLOGIC, INC.: DEALS, JANUARY 2023–JULY 2026 272 TABLE 290 INBODY CO., LTD.: COMPANY OVERVIEW 273 TABLE 291 INBODY CO., LTD.: PRODUCTS OFFERED 274 TABLE 292 INBODY CO., LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 275 TABLE 293 INBODY CO., LTD.: EXPANSIONS, JANUARY 2023–JULY 2026 276 TABLE 294 SELVAS HEALTHCARE, INC.: COMPANY OVERVIEW 277 TABLE 295 SELVAS HEALTHCARE, INC.: PRODUCTS OFFERED 278 TABLE 296 SELVAS HEALTHCARE, INC: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 279 TABLE 297 IMPEDIMED LIMITED: COMPANY OVERVIEW 280 TABLE 298 IMPEDIMED LIMITED: PRODUCTS OFFERED 281 TABLE 299 DMS IMAGING: COMPANY OVERVIEW 282 TABLE 300 DMS IMAGING: PRODUCTS OFFERED 283 TABLE 301 DMS IMAGING: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 284 TABLE 302 DMS IMAGING: DEALS, JANUARY 2023–JULY 2026 284 TABLE 303 A&D COMPANY, LIMITED: COMPANY OVERVIEW 285 TABLE 304 A&D COMPANY, LIMITED: PRODUCTS OFFERED 286 TABLE 305 A&D COMPANY, LIMITED: DEALS, JANUARY 2023–JULY 2026 287 TABLE 306 XIAOMI CORPORATION: COMPANY OVERVIEW 288 TABLE 307 XIAOMI CORPORATION: PRODUCTS OFFERED 289 TABLE 308 XIAOMI CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 290 TABLE 309 TANITA CORPORATION: COMPANY OVERVIEW 291 TABLE 310 TANITA CORPORATION: PRODUCTS 291 TABLE 311 TANITA CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 293 TABLE 312 TANITA CORPORATION: DEALS, JANUARY 2023–JULY 2026 293 TABLE 313 SECA: COMPANY OVERVIEW 294 TABLE 314 SECA: PRODUCTS OFFERED 294 TABLE 315 SECA: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 295 TABLE 316 SECA: DEALS, JANUARY 2023–JULY 2026 295 TABLE 317 WITHINGS: COMPANY OVERVIEW 296 TABLE 318 WITHINGS: PRODUCTS OFFERED 296 TABLE 319 WITHINGS: PRODUCT AND SERVICES LAUNCHES, JANUARY 2023–JULY 2026 297 TABLE 320 WITHINGS: DEALS, JANUARY 2023–JULY 2026 297 TABLE 321 COSMED S.R.L.: COMPANY OVERVIEW 299 TABLE 322 COSMED S.R.L.: PRODUCTS OFFERED 299 TABLE 323 COSMED S.R.L.: DEALS, JANUARY 2023–JULY 2026 300 TABLE 324 RJL SYSTEMS: COMPANY OVERVIEW 301 TABLE 325 RJL SYSTEMS: PRODUCTS OFFERED 301 TABLE 326 CHARDER ELECTRONIC CO., LTD.: COMPANY OVERVIEW 302 TABLE 327 CHARDER ELECTRONIC CO., LTD.: PRODUCTS OFFERED 302 TABLE 328 CHARDER ELECTRONIC CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 303 TABLE 329 BODYSTAT LIMITED: COMPANY OVERVIEW 304 TABLE 330 BODYSTAT LIMITED: PRODUCTS OFFERED 304 TABLE 331 MALTRON INTERNATIONAL LTD.: COMPANY OVERVIEW 305 TABLE 332 AKERN S.R.L.: COMPANY OVERVIEW 306 TABLE 333 BIOTEKNA: COMPANY OVERVIEW 307 TABLE 334 BIODYNAMICS CORPORATION: COMPANY OVERVIEW 307 TABLE 335 MICROLIFE CORPORATION: COMPANY OVERVIEW 308 TABLE 336 NUMED S.A.R.L.: COMPANY OVERVIEW 309 TABLE 337 TONGYONG TIZHI HEALTH TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 310 TABLE 338 FOOK TIN TECHNOLOGIES LTD.: COMPANY OVERVIEW 311 TABLE 339 OSTEOSYS CORP.: COMPANY OVERVIEW 312 TABLE 340 EXERTECH: COMPANY OVERVIEW 312 TABLE 341 SHANGHAI GOLDENWELL MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 313 FIGURE 1 MARKET SCENARIO 36 FIGURE 2 GLOBAL BODY COMPOSITION ANALYZERS MARKET, 2024–2031 37 FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BODY COMPOSITION ANALYZERS MARKET, 2023–2025 38 FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF BODY COMPOSITION ANALYZERS MARKET 38 FIGURE 5 HIGH-GROWTH SEGMENTS IN BODY COMPOSITION ANALYZERS MARKET, 2026–2031 39 FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 40 FIGURE 7 MARKET TRENDS SIGNAL STRONG FUTURE FOR PORTABLE, CONSUMER-GRADE, AND ADVANCED BODY COMPOSITION ASSESSMENT 41 FIGURE 8 HOSPITALS & CLINICS DOMINATED MARKET IN 2025 42 FIGURE 9 CHINA TO REGISTER HIGHEST GROWTH RATE TILL 2031 43 FIGURE 10 BODY COMPOSITION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44 FIGURE 11 2030 PROJECTIONS: MEN VS. WOMEN, BY BMI CATEGORY 46 FIGURE 12 BODY COMPOSITION ANALYZERS MARKET: PORTER’S FIVE FORCES ANALYSIS 59 FIGURE 13 BODY COMPOSITION ANALYZERS MARKET: SUPPLY CHAIN ANALYSIS 63 FIGURE 14 BODY COMPOSITION ANALYZERS MARKET: VALUE CHAIN ANALYSIS 64 FIGURE 15 BODY COMPOSITION ANALYZERS MARKET ECOSYSTEM 66 FIGURE 16 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2025 (USD) 70 FIGURE 17 AVERAGE SELLING PRICE TREND, BY MODALITY, 2025 (USD) 71 FIGURE 18 AVERAGE SELLING PRICE TREND, BY REGION, 2025 (USD) 73 FIGURE 19 REVENUE SHIFT AND NEW REVENUE POCKETS FOR BODY COMPOSITION ANALYZERS DEVICES MARKET 79 FIGURE 20 INVESTMENT & FUNDING SCENARIO 80 FIGURE 21 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR BODY COMPOSITION ANALYZERS PATENTS, JANUARY 2015–JUNE 2026 92 FIGURE 22 BODY COMPOSITION ANALYZERS MARKET: AI USE CASES 97 FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BODY COMPOSITION ANALYZERS 106 FIGURE 24 KEY BUYING CRITERIA FOR BODY COMPOSITION ANALYZERS, BY END USER 107 FIGURE 25 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET SNAPSHOT 157 FIGURE 26 ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET SNAPSHOT 187 FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN BODY COMPOSITION ANALYZERS MARKET (2023−2025) 239 FIGURE 28 GLOBAL BODY COMPOSITION ANALYZERS MARKET SHARE, 2025 240 FIGURE 29 US BODY COMPOSITION ANALYZERS MARKET SHARE, 2025 242 FIGURE 30 EUROPE BODY COMPOSITION ANALYZERS MARKET SHARE, 2025 243 FIGURE 31 BODY COMPOSITION ANALYZERS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 246 FIGURE 32 BODY COMPOSITION ANALYZERS MARKET: COMPANY FOOTPRINT 247 FIGURE 33 BODY COMPOSITION ANALYZERS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 254 FIGURE 34 EV/EBITDA OF KEY VENDORS 257 FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 257 FIGURE 36 BODY COMPOSITION ANALYZERS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 258 FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2025) 263 FIGURE 38 OMRON CORPORATION: COMPANY SNAPSHOT (2025) 267 FIGURE 39 HOLOGIC, INC.: COMPANY SNAPSHOT (2025) 271 FIGURE 40 INBODY CO., LTD.: COMPANY SNAPSHOT (2025) 274 FIGURE 41 SELVAS HEALTHCARE, INC.: COMPANY SNAPSHOT (2025) 278 FIGURE 42 IMPEDIMED LIMITED: COMPANY SNAPSHOT (2025) 281 FIGURE 43 DMS IMAGING: COMPANY SNAPSHOT (2025) 283 FIGURE 44 A&D COMPANY, LIMITED: COMPANY SNAPSHOT (2025) 286 FIGURE 45 XIAOMI CORPORATION: COMPANY SNAPSHOT (2025) 289 FIGURE 46 BODY COMPOSITION ANALYZERS MARKET: RESEARCH DESIGN 314 FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 319 FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 319 FIGURE 49 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 320 FIGURE 50 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 321 FIGURE 51 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 322 FIGURE 52 REVENUE SHARE ANALYSIS ILLUSTRATION: GE HEALTHCARE (2025) 323 FIGURE 53 TOP-DOWN APPROACH 324 FIGURE 54 BOTTOM-UP APPROACH 324 FIGURE 55 DEMAND-SIDE APPROACH 326 FIGURE 56 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF BODY COMPOSITION ANALYZERS MARKET (2026–2031) 327 FIGURE 57 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 328 FIGURE 58 DATA TRIANGULATION METHODOLOGY 329

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們